Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: A technical review

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2677-2683

  Moran, Antoinette ^a,o   Becker, Dorothy ^b   Casella, Samuel J ^c,j   Gottlieb, Peter A ^d   Kirkman, M Sue ^e   Marshall, Bruce C ^f   Slovis, Bonnie ^g   Alexander, Paula ^h   Beall, Robert J ^f   Brunzell, Carol ⁱ   Campbell III, Preston W ^f   Chin, Melissa ^f   Cohen, Richard C ^k   Brooks, Joan Finnegan ^l   George, Cynthia ^f   Hazle, Leslie ^f   Katz, Marcia ^m   McKeon, Catherine ⁿ   Onady, Gary ^p   Robinson, Karen A ^q   Rodgers, Theresa ^r   Sabadosa, Kathryn A ^s   Schindler, Terri ^t   Stecenko, Arlene ^u   Wood, Mary E ^c   Young, David ^v   more..

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e AMERICAN DIABETES ASSOCIATION   (United States)

^f CYSTIC FIBROSIS FOUNDATION   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h East Tennessee Children's Hospital   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^j CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

^k KAISER PERMANENTE   (United States)

^l Patient Focused Market Research   (United States)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

^o UNIVERSITY OF MINNESOTA   (United States)

^p WRIGHT STATE UNIVERSITY   (United States)

^q JOHNS HOPKINS UNIVERSITY   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^s DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^t CASE WESTERN RESERVE UNIVERSITY   (United States)

^u EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v Intermountain Cystic Fibrosis Adult Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

AUTOIMMUNE DISEASE; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES MELLITUS; DIABETES MELLITUS; DIET RESTRICTION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; LUNG FUNCTION; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW;

CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE;

EID: 79951703877     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1279     Document Type: Review

References (79)

1. Ode KL, Frohnert B, Laguna T, Phillips J, Holmes B, Regelmann W, Thomas W, Moran AM. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 25 February 2010 [Epub ahead of print]
2. Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial- Type 1. Diabetes Care 2009;32:1603-1607
3. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004;21:691-696 (Pubitemid 38916212)
4. Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, Pinget M, Kessler R, Kessler L. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008;40:502-506
5. Elder DA, Wooldridge JL, Dolan LM, D'Alessio DA. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007;151:653-658 (Pubitemid 350116132)
6. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 2005;25: 715-717 (Pubitemid 40528767)
7. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631
8. Casas L, Berry DR, Logan K, Copeland KC, Royall JA. Cystic fibrosis-related diabetes in an extremely young patient. J Cyst Fibros 2007;6:247-249 (Pubitemid 46567789)
9. Gelfand IM, Eugster EA, Haddad NG. Infancy- onset cystic fibrosis-related diabetes. Diabetes Care 2005;28:2593-2594 (Pubitemid 41384327)
10. Lombardi F, Raia V, Spagnuolo MI, Nugnes R, Valerio G, Ciccarelli G, Franzese A. Diabetes in an infant with cystic fibrosis. Pediatr Diabetes 2004;5:199-201 (Pubitemid 40057689)
11. Siahanidou T, Mandyla H, Doudounakis S, Anagnostakis D. Hyperglycaemia and insulinopenia in a neonate with cystic fibrosis. Acta Paediatrica 2005;94:1837-1840 (Pubitemid 43155602)
12. Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008; 31:1789-1794
13. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003;142:128-132 (Pubitemid 36232900)
14. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005;146:681-687 (Pubitemid 40616255)
15. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B, Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-350
16. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996;81: 1267-1272 (Pubitemid 26084003)
17. Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984;15:278-284 (Pubitemid 15162478)
18. Löhr M, Goertchem P, Nizze H, Gould NS, Gould VE, Oberholzer M, Heitz PU, Klöppel G. Cystic fibrosis associated islet changes may provide a basis for diabetes: an immunocytochemical and morphometrical study. Virchows Archiv A Pathol Anat Histopathol 1989;414:179-185 (Pubitemid 19045953)
19. Cucinotta D, De Luca D, Arrigo T, De Benedetto A, Sferlazzas C, Gigante A, Rigoli L, Magazzu G. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol 1994;7:13-17 (Pubitemid 24133746)
20. De Schepper J, Hachimi-Idrissi S, Smitz J, Dab I, Loeb H. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res 1992;38:260-263 (Pubitemid 23185852)
21. Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr 1977;90: 751-755 (Pubitemid 8082243)
22. Arrigo T, Cucinotta D, Conti Nibali S, Di Cesare E, Di Benedetto A, Magazzù G, De Luca F. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr 1993;82: 249-253 (Pubitemid 23107541)
23. Lanng S, Thorsteinsson B, Røder ME, Orskov C, Holst JJ, Nerup J, Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinologica 1993;128:207-214 (Pubitemid 23100875)
24. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991;118: 715-723
25. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008;152:540-545
26. Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Levesquie R, Perrier J, Karelis AD, Chiasson J-L, Rabasa-Lhoret R. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007;6:376-383 (Pubitemid 350028700)
27. Cucinotta D, Conti Nibali S, Arrigo T, Di Benedetto A, Magazzù G, Di Cesare E, Costantino A, Pezzino V, De Luca F. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990;34:33-38
28. Cucinotta D, Arrigo T, De Luca F, Di Benedetto A, Lombardo F, Scoglio R, Sferlazzas C, Magazzù G. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol 1996;134:731-736
29. De Luca F, Arrigo T, Di Benedetto A, Tedeschi A, Sferlazzas C, Crisafulli G, Di Cesare E, Romano G, Magazzù G, Cucinotta D. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. Horm Res 1995; 44:45-50
30. Holl RW, Wolf A, Thon A, Bernhard M, Buck C, Missel M, Heinze E, von der Hardt H, Teller WM. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients. JPGN 1997;25:188-193 (Pubitemid 27311382)
31. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, Messina MF, Crisafulli G, Wasniewska M, Valenzise M, Cucinotta D. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003;149:53-59 (Pubitemid 36874204)
32. Miller RJ, Tildesley HD, Wilcox PG, Zhang H, Kreisman SH. Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study. Can Respir J 2008;15:291-294
33. Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Diabete Metab 2007;33:213-219 (Pubitemid 46863411)
34. Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994; 43:163-167 (Pubitemid 24061847)
35. Cucinotta D, De Luca F, Gigante A, Arrigo T, Di Benedetto A, Tedeschi A, Lombardo F, Romano G, Sferlazzas C. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994;130:253-258 (Pubitemid 24117905)
36. Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994;41:217-223 (Pubitemid 24239927)
37. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER. Insulin sensitivity in cystic fibrosis. Diabetes 1994;43:1020-1026 (Pubitemid 24230707)
38. Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997;130:948-956 (Pubitemid 27495124)
39. Hardin DS, LeBlanc A, Marshall G, Seilheimer DK. Mechanism of insulin resistance in cystic fibrosis. Am J Physiol 2001; 281:E1022-E1028
40. Kien CL, Horswill CA, Zipf SB, McCoy KS, O'Dorisio T. Elevated hepatic glucose production in children with cystic fibrosis. Pediatr Res 1995;37:600-605
41. Hardin DS, LeBlanc A, Para L, Seilheimer DK. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 1999;48:1082-1087 (Pubitemid 29226355)
42. Ali BR. Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells? Med Hypotheses 2009; 72:55-57
43. Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury. Diabetes 2006;55:1939-1945 (Pubitemid 44509965)
44. Carrington M, Krueger LJ, Holsclaw DS Jr, Iannuzzi MC, Dean M, Mann D. Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57- molecules. J Clin Immunol 1994;14:353-358
45. Minicucci L, Cotellessa M, Pittaluga L, Minuto N, d'Annunzio G, Azanzini MA, Lorini R. Beta-cell autoantibodies and diabetes mellitus family history in cystic fi- brosis. J Pediatr Endocrinol Metab 2005; 18:755-760 (Pubitemid 41309338)
46. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D, Karamouzis M, Demitriadou A. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocirnol Metab 2000; 13:319-324 (Pubitemid 30163758)
47. De Luca F, Arrigo T, Conti Nibali S, Sferlazzas C, Gigante A, Di Cesare E, Cucinotta D. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991;23:495-498
48. Geffner ME, Lippe BM, Maclaren NK, Riley WJ. Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis. J Pediatr 1988;112:419-421 (Pubitemid 18079825)
49. Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madsen HO, Schwartz M, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993;82:150-154 (Pubitemid 23101484)
50. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001;90:860-867 (Pubitemid 32762829)
51. Atlas AB, Finegold DN, Becker D, Trucco M, Kurland G. Diabetic ketoacidosis in cystic fibrosis. AJDC 1992;146:1457-1458
52. Swartz LM, Laffel LM. A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema. Pediatr Diabetes 2008;9:426-430
53. Blackman SM, Hsu S, Ritter SE, Naughton KM, Wright FA, Drumm ML, Knowles MR, Cutting GR. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009;52:1858-1865
54. Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, Cutting GR. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab 2009; 94:1302-1309
55. Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Gradbar S, Chelly J, Bienvenu T. Calpain 10 and development of diabetes mellitus in cystic fibrosis. J Cyst Fibros 2006;5:47-51 (Pubitemid 43137161)
56. Figueroa V, Milla C, Parks EJ, Schwarzenberg SJ, Moran A. Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr 2002;75:1005-1011 (Pubitemid 34547529)
57. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007;30:1056-1061 (Pubitemid 46684624)
58. Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 2006;29:2660-2663 (Pubitemid 44912195)
59. van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 2008;7:515-519
60. Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998;92:871-872 (Pubitemid 28360617)
61. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151:684-687
62. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988;112:373-377 (Pubitemid 18079818)
63. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Resp Crit Care Med 2001;162:891-895
64. Kien CL, Zipf WB, Horswill CA, Denne SC, McCoy KS, O'Dorisio TM. Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis. Am J Clin Nutr 1996;64:608-614 (Pubitemid 26334241)
65. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998;101:433-437 (Pubitemid 28136419)
66. Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001;50:1336-1343 (Pubitemid 32500166)
67. Moran A, Basu R, Milla C, Jensen MD. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 2004;53:1467-1472 (Pubitemid 39410388)
68. Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 2005;81:421-426 (Pubitemid 43073344)
69. Franzese A, Spagnuolo MI, Sepe A, Valerio G, Mozzillo E, Raia V. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? (Letter). Diabetes Care 2005; 28:2333 (Pubitemid 41242497)
70. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica 1994;83: 849-853 (Pubitemid 24281615)
71. Mohan K, Israel KL, Miller H, Grainger R, Ledson MJ, Walshaw MJ. Long-term effect of insulin treatment in cystic fibrosisrelated diabetes. Respiration 2008;76: 181-186
72. Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P, Raia V. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatr Diabetes 2009;10:162-167
73. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic fibrosis-related diabetes mellitus. Acta Paediatr 2001;90:515-519 (Pubitemid 32552133)
74. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy trial. Diabetes Care 2009;32:1783-1788
75. Bizzarri C, Lucidi V, Ciampalini P, Bella S, Russo B, Cappa M. Clincial effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006;29: 1-4
76. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007;6:101-109 (Pubitemid 46394299)
77. Ntimbane T, Krishnamoorthy P, Huot C, Legault L, Jacob SV, Brunet S, Levy, E, Guéraud F, Lands LC, Comte B. Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 2008;7:373-384
78. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28:2141-2144
79. Sims EJ, Green MW, Mehta A. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 2005; 28:1581-1587